Literature DB >> 19864037

Ursodeoxycholic acid and primary biliary cirrhosis: EASL and AASLD guidelines.

Emmanuel A Tsochatzis, Kurinchi S Gurusamy, Christian Gluud, Andrew K Burroughs.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19864037     DOI： 10.1016/j.jhep.2009.09.015

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  6 in total

1.  The therapeutic effect of UDCA is a factor in determining the prognosis of primary biliary cirrhosis.

Authors:  Mikio Zeniya; Takashi Wada
Journal:  J Gastroenterol       Date:  2014-06-05       Impact factor: 7.527

Review 2.  The Cholangiopathies.

Authors:  Konstantinos N Lazaridis; Nicholas F LaRusso
Journal:  Mayo Clin Proc       Date:  2015-05-06       Impact factor: 7.616

3.  [Treatment of chronic itch in systemic disease. Current standards].

Authors:  T Mettang; S Ständer; A E Kremer
Journal:  Internist (Berl)       Date:  2015-12       Impact factor: 0.743

4.  Subtle presentation of active primary biliary cirrhosis in chronic hepatitis B: a case report.

Authors:  Asad Javaid; Mugilan Poongkunran; Felicia D Allard; Win Kyaw; Htet Htet Maung; Daryl Lau
Journal:  Gastroenterol Rep (Oxf)       Date:  2016-02-17

5.  Emperipolesis mediated by CD8+ T cells correlates with biliary epithelia cell injury in primary biliary cholangitis.

Authors:  Su-Xian Zhao; Wen-Cong Li; Na Fu; Guang-de Zhou; Shu-Hong Liu; Li-Na Jiang; Yu-Guo Zhang; Rong-Qi Wang; Yue-Min Nan; Jing-Min Zhao
Journal:  J Cell Mol Med       Date:  2019-12-18       Impact factor: 5.310

6.  Ursodeoxycholic acid improves bilirubin but not albumin in primary biliary cirrhosis: further evidence for nonefficacy.

Authors:  Emmanuel A Tsochatzis; Maurille Feudjo; Cristina Rigamonti; Jiannis Vlachogiannakos; James R Carpenter; Andrew K Burroughs
Journal:  Biomed Res Int       Date:  2013-07-24       Impact factor: 3.411
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.